These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 8158905

  • 1. Pivotal role of colony stimulating factor-1 in lupus nephritis.
    Rubin Kelley V, Bloom RD, Yui MA, Martin C, Price D.
    Kidney Int Suppl; 1994 Feb; 45():S83-5. PubMed ID: 8158905
    [Abstract] [Full Text] [Related]

  • 2. TNF-alpha enhances colony-stimulating factor-1-induced macrophage accumulation in autoimmune renal disease.
    Moore KJ, Yeh K, Naito T, Kelley VR.
    J Immunol; 1996 Jul 01; 157(1):427-32. PubMed ID: 8683148
    [Abstract] [Full Text] [Related]

  • 3. Enhanced response of macrophages to CSF-1 in autoimmune mice: a gene transfer strategy.
    Moore KJ, Naito T, Martin C, Kelley VR.
    J Immunol; 1996 Jul 01; 157(1):433-40. PubMed ID: 8683149
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Novel and enhanced IL-1 gene expression in autoimmune mice with lupus.
    Boswell JM, Yui MA, Endres S, Burt DW, Kelley VE.
    J Immunol; 1988 Jul 01; 141(1):118-24. PubMed ID: 3259964
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased macrophage colony-stimulating factor in neonatal and adult autoimmune MRL-lpr mice.
    Yui MA, Brissette WH, Brennan DC, Wuthrich RP, Rubin-Kelley VE.
    Am J Pathol; 1991 Aug 01; 139(2):255-61. PubMed ID: 1867317
    [Abstract] [Full Text] [Related]

  • 10. MRL/lpr and MRL+/+ macrophage DNA synthesis in the absence and the presence of colony-stimulating factor-1 and granulocyte-macrophage colony-stimulating factor.
    Hamilton JA, Chan J, Byrne RJ, Bischof RJ, Jaworowski A, Kanagasundaram V.
    J Immunol; 1998 Dec 15; 161(12):6802-11. PubMed ID: 9862711
    [Abstract] [Full Text] [Related]

  • 11. Expansion and high proliferative potential of the macrophage system throughout life time of lupus-prone NZB/W and MRL lpr/lpr mice. Lack of down-regulation of extramedullar macrophage proliferation in the postnatal period.
    Müller M, Emmendörffer A, Lohmann-Matthes ML.
    Eur J Immunol; 1991 Sep 15; 21(9):2211-7. PubMed ID: 1889463
    [Abstract] [Full Text] [Related]

  • 12. Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis.
    Boswell JM, Yui MA, Burt DW, Kelley VE.
    J Immunol; 1988 Nov 01; 141(9):3050-4. PubMed ID: 3262676
    [Abstract] [Full Text] [Related]

  • 13. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 14. Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice.
    Zavala F, Masson A, Hadaya K, Ezine S, Schneider E, Babin O, Bach JF.
    J Immunol; 1999 Nov 01; 163(9):5125-32. PubMed ID: 10528219
    [Abstract] [Full Text] [Related]

  • 15. Cultured mesangial cells from autoimmune MRL-lpr mice have decreased secreted and surface M-CSF.
    Brennan DC, Jevnikar AM, Bloom RD, Brissette WH, Singer GG, Kelley VR.
    Kidney Int; 1992 Aug 01; 42(2):279-84. PubMed ID: 1405313
    [Abstract] [Full Text] [Related]

  • 16. Transplant approach establishes that kidneys are responsible for serum CSF-1 but require a stimulus in MRL-lpr mice.
    Naito T, Griffiths RC, Coffman TM, Kelley VR.
    Kidney Int; 1996 Jan 01; 49(1):67-74. PubMed ID: 8770950
    [Abstract] [Full Text] [Related]

  • 17. Circulating CSF-1 promotes monocyte and macrophage phenotypes that enhance lupus nephritis.
    Menke J, Rabacal WA, Byrne KT, Iwata Y, Schwartz MM, Stanley ER, Schwarting A, Kelley VR.
    J Am Soc Nephrol; 2009 Dec 01; 20(12):2581-92. PubMed ID: 19926892
    [Abstract] [Full Text] [Related]

  • 18. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec 01; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 19. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2005 May 01; 52(5):1522-33. PubMed ID: 15880599
    [Abstract] [Full Text] [Related]

  • 20. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.